Detalles de la búsqueda
1.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029412
2.
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma.
Oncologist
; 27(7): 534-e546, 2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285484
3.
Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology Practice.
Oncologist
; 27(3): 183-190, 2022 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274713
4.
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.
Oncologist
; 27(4): 292-298, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380713
5.
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.
N Engl J Med
; 380(13): 1226-1234, 2019 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30917258
6.
Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis.
Breast Cancer Res Treat
; 187(1): 275-285, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392843
7.
A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance).
Support Care Cancer
; 28(12): 6085-6094, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32307658
8.
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(1): 88-99, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30509771
9.
Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial.
Oncologist
; 24(11): 1497-1501, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31399500
10.
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
N Engl J Med
; 372(10): 923-32, 2015 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25738668
11.
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
Breast Cancer Res Treat
; 172(3): 603-610, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30159789
12.
Modafinil Moderates the Relationship Between Cancer-Related Fatigue and Depression in 541 Patients Receiving Chemotherapy.
J Clin Psychopharmacol
; 36(1): 82-5, 2016 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26658264
13.
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.
Br J Clin Pharmacol
; 81(6): 1134-41, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26859101
14.
Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.
Future Oncol
; 12(15): 1759-68, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27093976
15.
"Enjoy glass of wine before eating:" a randomized trial to test the orexigenic effects of this advice in advanced cancer patients.
Support Care Cancer
; 24(9): 3739-46, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27039205
16.
MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy.
Support Care Cancer
; 24(3): 1071-8, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26248652
17.
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up.
Support Care Cancer
; 24(3): 1219-26, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26298334
18.
Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.
Support Care Cancer
; 24(3): 1339-47, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26329396
19.
5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.
Cancer
; 121(15): 2537-43, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25930719
20.
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia.
Br J Haematol
; 168(6): 796-805, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25403830